Omega Therapeutics (OMGA)
(Real Time Quote from BATS)
$2.37 USD
-0.03 (-1.25%)
Updated Jun 26, 2024 03:06 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
OMGA 2.37 -0.03(-1.25%)
Will OMGA be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for OMGA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OMGA
Nurix Therapeutics (NRIX) Surges 20.6%: Is This an Indication of Further Gains?
Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Tops Revenue Estimates
OMGA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should You Invest in Novo Nordisk (NVO) Ahead of Q1 Earnings?
Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
Other News for OMGA
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
Omega Therapeutics announces election of Richard Kender to its board
Omega Pacific Launches Drilling, Eyes Expansion
Omega Pacific Commences Maiden Drill Program at Its Williams Property
Raymond James starts Omega at outperform, cites platform